Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Non-Current Assets (2016 - 2025)

Bio Key International's Non-Current Assets history spans 16 years, with the latest figure at $6.4 million for Q3 2025.

  • For Q3 2025, Non-Current Assets rose 244.28% year-over-year to $6.4 million; the TTM value through Sep 2025 reached $6.4 million, up 244.28%, while the annual FY2024 figure was $6.7 million, 255.09% up from the prior year.
  • Non-Current Assets for Q3 2025 was $6.4 million at Bio Key International, down from $6.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $6.7 million in Q4 2024 and bottomed at $1.8 million in Q2 2024.
  • The 5-year median for Non-Current Assets is $3.8 million (2021), against an average of $3.9 million.
  • The largest annual shift saw Non-Current Assets surged 264.64% in 2021 before it tumbled 62.5% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $3.8 million in 2021, then tumbled by 37.19% to $2.4 million in 2022, then dropped by 19.69% to $1.9 million in 2023, then soared by 255.09% to $6.7 million in 2024, then decreased by 5.37% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Non-Current Assets are $6.4 million (Q3 2025), $6.5 million (Q2 2025), and $6.6 million (Q1 2025).